Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 864 Lymphoma, T-Cell, Cutaneous 143 Uveal Melanoma 96 Skin Neoplasms 96 Mycosis Fungoides 95 Sezary Syndrome 81 Carcinoma, Basal Cell 76 Neoplasm Metastasis 68 Lymphoma 64 Lymphoma, Non-Hodgkin 63 Keratosis, Actinic 61 Neoplasms 57 Leukemia, Lymphocytic, Chronic, B-Cell 57 Carcinoma, Renal Cell 55 Carcinoma, Non-Small-Cell Lung 54 Lymphoma, B-Cell, Marginal Zone 53 Precursor Cell Lymphoblastic Leukemia-Lymphoma 52 Lymphoma, Mantle-Cell 52 Lymphoma, Large B-Cell, Diffuse 52 Lymphoma, Follicular 52 Hodgkin Disease 52 Lymphoma, Large-Cell, Immunoblastic 50 Carcinoma, Merkel Cell 50 Burkitt Lymphoma 49 Brain Neoplasms 46 Multiple Myeloma 44 Lymphoma, Large-Cell, Anaplastic 41 Recurrence 40 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 40 Breast Neoplasms 40

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Bowen's Disease × Dermatologic × Clear all

NCT02085395 2014-03-14

AK

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed

Bowen's Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡